(Q36682035)

15 August 2017

1 reference

title

Canavan disease: from spongy degeneration to molecular analysis (English)

1 reference

15 August 2017

1 reference

Matalon R

1

1 reference

15 August 2017

Michals K

series ordinal

2

1 reference

15 August 2017

Kaul R

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

The Journal of Pediatrics

15 August 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 August 2017

127

1 reference

15 August 2017

4

1 reference

15 August 2017

511-517

1 reference

SCHILDER'S ENCEPHALITIS PERIAXIALIS DIFFUSA

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

SPONGY DEGENERATION OF THE CENTRAL NERVOUS SYSTEM IN INFANCY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Familial idiocy with spongy degeneration of the central nervous system of van Bogaert--Bertrand type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

SPONGY DEGENERATION OF THE NERVOUS SYSTEM. A REPORT OF FOUR CASES WITH A REVIEW OF THE LITERATURE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

SPONGY DEGENERATION OF WHITE MATTER: CANAVAN'S SCLEROSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Spongy degeneration of the central nervous system (Van Bogaert and Bertrand type; Canavan's disease)A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Familial spongy degeneration of the central nervous system (Van Bogaert-Bertrand disease). An ultrastructural study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with canavan disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Canavan disease: biochemical and molecular studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

N-acetylaspartic aciduria in a child with a progressive cerebral atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Spongy degeneration of the neuraxis (Canavan-van Bogaert disease) and N-acetylaspartic aciduria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Aspartoacylase deficiency and Canavan disease in Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Canavan disease: findings in four new cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Studies on the function of N-acetyl aspartic acid in brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Studies on the role of N-acetylaspartic acid in mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Purification and Characterization of the Heat-Stable Factors Essential for the Conversion of Lignoceric Acid to Cerebronic Acid and Glutamic Acid: Identification of N-Acetyl-l-Aspartic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

A gas chromatographic method for the determination of N-acetyl-L-aspartic acid, N-acetyl-alpha-aspartylglutamic acid and beta-citryl-L-glutamic acid and their distributions in the brain and other organs of various species of animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Decreased brain N-acetylaspartate in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Decrease in N-acetyl-L-aspartic acid in brain of myodystrophic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

In vivo detection of metabolic changes in a mouse model of scrapie using nuclear magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

N-acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer's disease post-mortem brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Purification, characterization, and localization of aspartoacylase from bovine brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Novel (cys152>arg) missense mutation in an Arab patient with Canavan disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Spongy degeneration of the CNS: an instance of the rare juvenile form

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Juvenile form of spongy degeneration of the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Magnetic resonance imaging in juvenile Canavan disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Computed tomography in the diagnosis of Canavan's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Cerebral spongy degeneration of infancy. A biochemical and ultrastructural study of affected twins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Spongy Degeneration of the CNS in Infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Mitochondrial cytopathy or Leigh's syndrome? Mitochondrial abnormalities in Spongiform encephalopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

CT findings in a case of deficiency of 3-hydroxy-3-methylglutaryl-CoA-lyase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Spongy degeneration of the white matter of the central nervous system associated with hyperglycinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Jewish diseases and origins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Prenatal diagnosis of Canavan disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Prenatal detection of Canavan disease by measurement of N-acetyl-L-aspartate in amniotic fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Prenatal diagnosis for Canavan disease: the use of DNA markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

Immunohistochemical localization of N-acetylaspartate in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970105-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(95)70105-2

1 reference

15 August 2017

1 reference